The Institute for Research, Education, & Training in Addictions (IRETA) is a public health organization that provides free trainings, webinars, case studies of interventions, and prescriber education to help people respond to substance use and related problems. 

This report provides summary guidance and recommendations from CDC and the U.S. Department of Health and Human Services for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons who use drugs illicitly. It also summarizes existing evidence of effectiveness for practices to support delivery of integrated prevention services.

This report documents the experiences of five programs that integrate employment services into treatment and recovery programs for people with substance use disorder (SUD). It offers recommendations for how to implement employment programs aimed at sustaining recovery from SUD and improving participants' economic well-being.

This is an issue brief from the Foundation for Opioid Response Efforts that gives an overview of the epidemiology of opioid use disorder among pregnant individuals in jails and prisons, the barriers they face, and an example of a program model that has addressed these barriers and provided evidence-based treatment in this setting. Recommendations are made to replicate this program. 

This is an academic paper discussing The Opioid Initiative, launched in Oregon in 2015, which focuses on integrating efforts to improve patient care and safety, and population health, by increasing access to nonopioid pain treatment, supporting medications for opioid use disorder and naloxone access for people taking opioids, decreasing opioid prescribing, and using data to inform policies and interventions. This state initiative has shown promising results. 

This is a report from the National Academy for State Health Policy (NASHP) that discusses the role that integrating substance use disorder treatment into primary care can play in mitigating the addiction crisis. Some of the topics discussed include Screening, Brief Intervention, and Referral to Treatment (SBIRT) and integrating medications for opioid use disorder (MOUD) into primary care. Considerations for state policies as well as payment and deliver reform are provided. 

This is an academic paper that discusses the role of telehealth in expanding access to medications for opioid use disorder in rural areas. The need for integrating telemedicine into primary care in rural areas is highlighted as well as how the coronavirus pandemic has loosened restrictions to providing these services.  

A toolkit from the National Resource Center for Academic Detailing (NaRCAD) the provides resources for academic detailing of opioid prescribing and treatment with medications for opioid use disorder (MOUD), including links to previous literature, resources, and patient education material.

This is a publication by the National Academy for State Health Policy (NASHP) that highlights strategies states are using to better deploy emergency intervention to reduce opioid overdose deaths, improve access to care, and provide better treatment services in rural areas.

This report also describes sustainable financing structures to support these strategies and services. There is also mention of unique rural barriers and how to overcome them as well as case studies of comprehensive community responses.

This is an academic paper that provides an overview of interventions for incarcerated people in the United States with opioid use disorder (OUD). There is also a specific focus on addressing the social determinants of health within this study.

This is a policy brief from the Harvard Institute of Politics that provides an overview of how the state of Massachusetts uses civil commitments to coerce people with substance use disorders into treatment. The different problems of this approach are discussed and potential solutions are proposed within this document.

This is an issue brief which provides an overview of the coverage and cost of several forms of medications for opioid use disorder (MOUD) for individuals with private insurance, Medicare, or Medicaid. The report also provides inconsistencies in policy among private and public health insurance programs and makes recommendations for promoting equitable coverage of MOUD for all insured patients.